Skip to content 
A nationwide recall has been issued for a specific lot of Xanax XR, the extended-release form of alprazolam, after the product failed a quality-control test tied to how the drug dissolves.
The recall was initiated by Viatris Specialty LLC on March 17, 2026, and the FDA classified it as a Class II recall on April 15, 2026, a category used when a product may cause temporary or medically reversible health problems, while the chance of serious harm is considered remote.
What Exactly Is Being Recalled
View this post on Instagram
The affected product is not all Xanax, and it is not every alprazolam prescription on the market. The recall covers Xanax XR (alprazolam extended-release tablets) 3 mg, packaged in 60-tablet bottles, with lot number 8177156 and an expiration date of February 28, 2027.
According to the recall notice, those bottles were distributed in the United States between August 27, 2024, and May 29, 2025.
The California State Board of Pharmacy, which posted the recall alert sent to pharmacies, said the product was pulled because it was “out of specification for dissolution.”
Why the Problem Matters
Xanax XR is part of the benzodiazepine class of medicines. FDA labeling for Xanax XR says it is indicated for the treatment of panic disorder, and alprazolam more broadly is widely used in anxiety-related care.
Because extended-release tablets are engineered to deliver medication over time, any failure in dissolution standards can raise questions about whether patients are getting the intended release profile.
That does not mean regulators are describing this as the most severe type of recall. According to People, the FDA’s Class II designation signals a more limited risk profile than a Class I recall.
Still, for a medication that acts on the central nervous system, even a moderate manufacturing concern is enough to trigger close scrutiny and a nationwide withdrawal of the affected lot.
What Patients Should Check Now
Patients should look at the prescription bottle label and confirm four details: Xanax XR, 3 mg, 60 tablets, and lot 8177156. If those details match, the medication falls within the recall.
Reports on the recall have advised consumers to stop using the affected pills and follow disposal instructions, but patients taking alprazolam regularly should also contact a pharmacist or prescribing clinician promptly, since benzodiazepines are not medications people should adjust casually on their own.
How to Dispose of the Recalled Pills
The FDA says the best option for most unused or recalled medicines is a drug take-back program. If that is not available, and the drug is not on the FDA flush list, the agency advises mixing the tablets with an undesirable substance such as dirt, cat litter, or used coffee grounds, sealing the mixture in a bag or container, and placing it in the household trash.
For now, the recall appears tightly limited to one identified lot. But for patients who rely on the drug, that narrow scope does not make the issue trivial. It makes the bottle in the medicine cabinet worth checking today.
